🇺🇸 Nivolumab and Relatlimab in United States

Nivolumab and Relatlimab (Nivolumab and Relatlimab) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Nivolumab and Relatlimab in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Nivolumab and Relatlimab approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Nivolumab and Relatlimab in United States?

University of Wisconsin, Madison is the originator. The local marketing authorisation holder may differ — check the official source linked above.